Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covidien’s Pipeline, NovoCure’s NovoTFF Set For FDA Panel Review

This article was originally published in The Gray Sheet

Executive Summary

FDA’s Neurological Devices panel is set to review Covidien’s Pipeline embolization device and NovoCure’s NovoTFF-100A brain tumor treatment kit during a March 17-18 meeting.

You may also be interested in...



Covidien’s Pipeline Gains Unanimous Panel Endorsement For Large Aneurysms

FDA’s Neurological Devices Panel unanimously endorsed safety and efficacy data on Covidien’s Pipeline aneurysm embolization device March 18.

Covidien’s Pipeline Gains Unanimous Panel Endorsement For Large Aneurysms

FDA’s Neurological Devices Panel unanimously endorsed safety and efficacy data on Covidien’s Pipeline aneurysm embolization device March 18.

Research In Brief

Covidien hernia repair

Related Content

Topics

UsernamePublicRestriction

Register

MT029842

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel